Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases

Details for Australian Patent Application No. 2009350151 (hide)

Owner Bristol-Myers Squibb Company

Inventors Jure-Kunkel, Maria; Lee, Francis Y.

Agent A J Park

Pub. Number AU-A-2009350151

PCT Pub. Number WO2011/011027

Priority 12/462,168 30.07.09 US; 61/226,910 20.07.09 US; PCT/ US2009/052209 30.07.09 US

Filing date 29 October 2009

Wipo publication date 27 January 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/385 (2006.01) - having two or more sulfur atoms in the same ring

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

9 February 2012 PCT application entered the National Phase

  PCT publication WO2011/011027 Priority application(s): WO2011/011027

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009350161-Gaming system bill validator

2009350143-Improving fuel efficiency for a piston engine using a super-turbocharger